Several key details have emerged regarding Medtronic plc (MDT) from recent reports. The medical technology company's price is currently at $81.04, with a global layoff. The company's stock has been down in comparison to competitors, though its position has seen an increase by V Square Quantitative Management LLC. Investment has been diverse, such as American Trust purchasing 296 shares of the stock and Scarborough Advisors LLC making a new investment. However, it is worth noting that Raleigh Capital Management Inc. has decreased its holdings in Medtronic plc. The company has released its full-year and Q4 fiscal 2024 financial results, and has also increased its dividend. Institutional shareholders have a significant hold on the company, owning 86% of it. Despite the underperformance of the stock, Medtronic's PillCam SB3 system has received 510 (k) clearance, a significant positive. Unfortunately, Medtronic's outlook has been disappointing to some investors. Nevertheless, the company's CEO, Geoff Martha, will speak at the upcoming Goldman Sachs global healthcare conference.
Medtronic Plc MDT News Analytics from Fri, 02 Feb 2024 08:00:00 GMT to Sun, 16 Jun 2024 21:15:47 GMT -
Rating -2
- Innovation 3
- Information 6
- Rumor -2
